Tel Aviv/Zurich, 11 August 2011 – SHL Telemedicine Ltd. (SIX Swiss Exchange:
SHLTN), a leading provider and developer of advanced personal telemedicine solutions,
announces that at its Annual General Meeting held in Tel Aviv on 10 August 2011,
shareholders approved all proposals put forward by the Board of Directors.
The SHL Board of Directors consists of nine members out of which the AGM approved
the re-election of eight members of the Board of Directors, whose term of office expired,
for another term. After his re-election as a director, Mr. Elon Shalev was elected as the
new Chairman of the Board of Directors. He follows Mr. Yoram Alroy, President and
Chairman of the Board, since the inception of the company in 1987, who will continue to
serve on the Board for another term and as President.
Elon Shalev is the co-founder of SHL and has served as a director of SHL since its
inception in 1987. From 1990 to 1993, he was SHL’s Chief Operating Officer. Mr. Shalev
was the founder of Channel 2 news in Israel and from 1993 to 1996 served as its CEO.
From 1996 to 1999, he was Editor in Chief of “Yediot Aharonot”, the largest daily
newspaper in Israel and from 2000 to 2001 he was an Executive Vice President of
Discount Investment Corporation Ltd. of the IDB group, one of the largest investment
and holding companies in Israel. Mr. Shalev is currently a private entrepreneur in the
telecom market and is the Chairman and co-founder of Logia Ltd., a global provider of
innovative mobile content solutions. In addition, Mr. Shalev serves as a senior advisor to
the Saban Capital Group and served as a Board member in several large and well
known Israeli firms like Bezeq (the Israeli national telecommunications provider), Yes (a
multi channel satellite broadcast company) and Bezeq International (a long distance
telecommunications provider). Mr. Shalev holds a BA degree in Political Science from
the University of Tel-Aviv, Israel. Nationality: Israeli. Age: 60.
For the AGM documents pls. go to http://localhost/oldshl/investors-
relations/general-meeting/.
About SHL Telemedicine
SHL Telemedicine Ltd. specializes in developing and marketing advanced personal
telemedicine systems as well as providing comprehensive telemedicine solutions
including medical call centers to individuals and to the healthcare community. As a
leading provider of remote health services in cardiology and in other medical areas, SHL
maintains business operations in Europe, mainly in Germany, and at its home market in
Israel. In the US, certain SHL telemedicine products are distributed by Philips
Healthcare. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885,
Security No.: 1128957). More information available at: www.shl-telemedicine.com.
For further information please contact:
- Erez Alroy, Co-CEO, Phone: +972 3561 22 12, [email protected]
- Assistant: Pauline Shavit, Phone: +972 3561 22 12, [email protected]
- Martin Meier-Pfister, IRF Communications, Phone: +41 43 244 81 40, [email protected]
Some of the information contained in this press release contains forward-looking statements.
Readers are cautioned that any such forward-looking statements are not guarantees of future
performance and involve risks and uncertainties, and that actual results may differ materially from
those in the forward-looking statements as a result of various factors. SHL Telemedicine
undertakes no obligation to publicly update or revise any forward-looking statements.
